Please login to the form below

Not currently logged in
Email:
Password:

decisions in time

This page shows the latest decisions in time news and features for those working in and with pharma, biotech and healthcare.

The Final Frontier

The Final Frontier

This is due to many factors and will certainly change over time but suffice it to say that medical cannabis is not a national trend in Canada. ... Prevalence is important too. Understanding how many people are affected by a disease at any given point in

Latest news

  • GSK signs up for the 'dawn of cognitive advertising' GSK signs up for the 'dawn of cognitive advertising'

    It also gives consumers easy access to information to make better decisions about their healthcare in real time. . ... Watson is already being readied to'see' health problems, and IBM says the new Watson Ads will help consumers make “more informed

  • Novo's ‘virtual mannequins’ win digital award at PMEA Novo's ‘virtual mannequins’ win digital award at PMEA

    Novo Nordisk's Decisions in Time picked up the Excellence in Digital/Social Media award earlier this week at the Pharmaceutical Market Excellence Awards (PMEA) in London. ... In addition to its virtual mannequins, Decisions in Time combines a bespoke

  • Novartis named digital pharma company of the year Novartis named digital pharma company of the year

    He serves as medical education at the company in the UK and played a vital role in Novo's Decisions in Time series of workshops to bring patient case studies to ... Digital solution for congress / symposium. Decisions in Time. By: emotive For: Novo

  • Boehringer continues award-winning ChatAFib tweet chat Boehringer continues award-winning ChatAFib tweet chat

    The social media discussion, which begins at 12pm (UK time), will this time focus on patient education, adherence and supporting better outcomes for patients with atrial fibrillation.  . ... it. Confront it. World Hepatitis Day work for the World

  • FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patients FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patients

    Increasingly, doctors and patients rely on diagnostics to help guide personalised treatment decisions,” he said. ... The approval of the cobas EGFR Mutation Test highlights the importance of sensitive, accurate tests that can be conducted in time to

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics